Centinel Spine completed initial cases with three different implant portfolios within its FLX™ platform of Integrated Interbody™ and non-integrated 3D-printed interbody fusion devices.
These initial cases included three different FLX devices: STALIF C FLX Cervical Integrated Interbody, STALIF M FLX Lumbar Integrated Interbody and ACTILIF C FLX Cervical Interbody. Centinel Spine, a privately-held company focused on anterior column reconstruction, received FDA 510(k) clearance to market these devices in 2Q18.
FLX is based on the company's established STALIF interbody devices, in a novel all-titanium lattice option. FLX devices feature solid and porous radiolucent sections designed to offer less mechanical stiffness and better visibility vs. solid titanium implants, as well as a proprietary FUSE-THRU™ trabecular scaffold for bony in-growth and on-growth.
Source: Centinel Spine